Last reviewed · How we verify
Maxillary infiltration anesthesia with 2%Lidocaine
At a glance
| Generic name | Maxillary infiltration anesthesia with 2%Lidocaine |
|---|---|
| Also known as | 2% Lignociane |
| Sponsor | Riyadh Colleges of Dentistry and Pharmacy |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Topical Cryoanesthesia Versus Benzocaine in Pediatric Dentistry (PHASE3)
- Pain and Anxiety in Pediatric Dentistry: Computer-Controlled vs. Traditional Anesthesia (NA)
- Exparel Versus Bupivacaine in Post-operative Pain Control (PHASE4)
- Derma Pen as Treatment of Gingivitis Induced by Orthodontics (NA)
- Use of Particulate Cortico- Cancellous Anterior Iliac Graft with Periosteum Membrane in Unilateral Alveolar Cleft Grafting Versus Particulate Cortico-cancellous Anterior Iliac Grafting Alone. (NA)
- Pain and Anxiety Levels of Sleeperone Electronic Anesthesia System in Pediatric Patients (NA)
- The Anesthetic Efficacy of Lidocaine and Articaine as Buccal Injection for Maxillary Premolar Teeth Extraction. (NA)
- A Novel Approach in Reducing Dental Pain and Anxiety of Pediatric Patient During Local Anesthesia. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: